Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading

Area of Science:

• Cardiology
• Molecular Biology
• Cellular Biology

Background:

• Cardiac hypertrophy is a compensatory response to stress, aiming to maintain cardiac output.
• While regression of cardiac hypertrophy is possible after etiological factor control, its molecular mechanisms are not fully understood.
• Autophagy plays a role in cellular homeostasis and stress adaptation.

Purpose of the Study:

• To investigate the role of autophagy in the regression of cardiac hypertrophy.
• To determine if autophagy is essential for the reversal of cardiac hypertrophy after stress removal.

Main Methods:

• Induction of cardiac hypertrophy in wild-type mice using angiotensin II infusion.
• Assessment of autophagy markers, including microtubule-associated protein 1 light chain 3 (LC3)-II, during hypertrophy regression.
• Comparison of cardiac hypertrophy regression in cardiac-specific Atg5-deficient (CKO) mice versus control (CTL) mice after stress unloading.

Main Results:

• Cardiac hypertrophy regression was observed in wild-type mice after angiotensin II withdrawal, accompanied by induced autophagy.
• Cardiac-specific Atg5-deficient mice exhibited significantly impaired regression of cardiac hypertrophy compared to controls.
• Regression of pressure overload-induced cardiac hypertrophy was also attenuated in Atg5-deficient mice.

Conclusions:

• Autophagy is a necessary molecular mechanism for the regression of cardiac hypertrophy.
• The findings suggest that promoting autophagy could be a therapeutic strategy for reversing cardiac hypertrophy.
• Targeting autophagy may offer a novel approach to manage cardiac hypertrophy during stress unloading.